Julie Papanek Grant
CIK 1673237 · last filed 2023-03-03
Julie Papanek Grant is a corporate insider who has filed 22 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $465.3K of DAWN on Mar 3, 2023. Across all open-market trades the lifetime net is −$19.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $205.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$205.28M
2
22
-$19.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 467,358 | $21.53 | $10.06M | -$26.77M | 19 | 2023-03-03 |
| PTGX | Director | 1,869,922 | $109.78 | $205.28M | $7.00M | 3 | 2017-05-26 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-03 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −25,000 | -$465.3K | EDGAR |
| 2023-02-03 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −25,000 | -$530.8K | EDGAR |
| 2023-01-04 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −25,000 | -$516.1K | EDGAR |
| 2022-12-12 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −4,358 | -$96.2K | EDGAR |
| 2022-12-05 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −10,000 | -$216.5K | EDGAR |
| 2022-11-03 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −10,000 | -$200.3K | EDGAR |
| 2022-10-05 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −10,000 | -$200.3K | EDGAR |
| 2022-09-22 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | −2,113,603 | -$11.38M | EDGAR |
| 2022-09-20 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −340,702 | -$6.96M | EDGAR |
| 2022-09-15 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −245,039 | -$5.82M | EDGAR |